FCGR2B Produits
(Fc Fragment of IgG, Low Affinity IIb, Receptor (CD32) (FCGR2B))
Catégories
The protein encoded by this gene is a low affinity receptor for the Fc region of immunoglobulin gamma complexes. The encoded protein is involved in the phagocytosis of immune complexes and in the regulation of antibody production by B-cells. Variations in this gene may increase susceptibilty to systemic lupus erythematosus (SLE). Several transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jun 2010].
antibodies-online.com est synonyme de produits de recherche de haute qualité. Cherchez, trouvez et commandez des outils avec des données de validation étendues, des images, des références. Notre service clientèle scientifique est toujours à votre disposition si vous avez des questions sur la sélection ou l'application de nos produits.
Catégories FCGR2B en vedette
FCGR2B Anticorps
High quality antibodies with extensive validation data.
FCGR2B Kits ELISA
Reliable ELISA kits for a wide range of species.
FCGR2B Protéines
Proteins for various applications incl. WB, ELISA, IF etc.
FCGR2B recommandé Anticorps
Produit
Reactivity
Application
Validations
N° du produit
Quantité
Fiche technique
Reactivity
Human, Monkey, Mouse
Application
WB, ELISA, FACS, IF (cc), IF (p), IHC (p), ICC, IHC (fro)
Validations
- (6)
N° du produit
ABIN761411
Quantité
100 μL
Fiche technique
Fiche technique
Reactivity
Human
Application
WB, ELISA, IHC (p)
Validations
- (5)
N° du produit
ABIN560858
Quantité
100 μg
Fiche technique
Fiche technique
Reactivity
Human
Application
WB, ELISA, IHC
Validations
- (5)
N° du produit
ABIN185377
Quantité
100 μg
Fiche technique
Fiche technique
FCGR2B recommandé Kits ELISA
Produit
Reactivity
Analytical Method
Validations
N° du produit
Quantité
Fiche technique
Reactivity
Human
Analytical Method
Quantitative Sandwich ELISA
Validations
- (1)
N° du produit
ABIN6955739
Quantité
96 tests
Fiche technique
Fiche technique
Reactivity
Mouse
Analytical Method
Quantitative Sandwich ELISA
Validations
- (1)
N° du produit
ABIN1979374
Quantité
96 tests
Fiche technique
Fiche technique
Reactivity
Human
Analytical Method
Quantitative Sandwich ELISA
Validations
- (1)
N° du produit
ABIN1889450
Quantité
96 tests
Fiche technique
Fiche technique
FCGR2B recommandé Protéines
Produit
Reactivity
Source
Validations
N° du produit
Quantité
Fiche technique
Reactivity
Human
Source
HEK-293 Cells
Validations
- (3)
N° du produit
ABIN7274288
Quantité
100 μg
Fiche technique
Fiche technique
Reactivity
Mouse
Source
HEK-293 Cells
Validations
- (3)
N° du produit
ABIN7274290
Quantité
100 μg
Fiche technique
Fiche technique
Reactivity
Cynomolgus
Source
HEK-293 Cells
Validations
- (3)
N° du produit
ABIN7274287
Quantité
100 μg
Fiche technique
Fiche technique
Dernières publications sur nos produits FCGR2B
: "Effects of terminal galactose residues in mannose α1-6 arm of Fc-glycan on the effector functions of therapeutic monoclonal antibodies." dans: mAbs, Vol. 11, Issue 5, pp. 826-836, (2020) (PubMed).: "Control of therapeutic IgG antibodies galactosylation during cultivation process and its impact on IgG1/FcγR interaction and ADCC activity." dans: Biologicals : journal of the International Association of Biological Standardization, Vol. 58, pp. 16-21, (2019) (PubMed).
: "Live simian immunodeficiency virus vaccine correlate of protection: immune complex-inhibitory Fc receptor interactions that reduce target cell availability." dans: Journal of immunology (Baltimore, Md. : 1950), Vol. 193, Issue 6, pp. 3126-33, (2014) (PubMed).
: "Fc gamma receptor glycosylation modulates the binding of IgG glycoforms: a requirement for stable antibody interactions." dans: Journal of proteome research, Vol. 13, Issue 12, pp. 5471-85, (2014) (PubMed).
: "Human FcγRII cytoplasmic domains differentially influence antibody-mediated dengue virus infection." dans: Journal of immunology (Baltimore, Md. : 1950), Vol. 190, Issue 11, pp. 5659-65, (2013) (PubMed).
: "Anti-peptidoglycan antibodies and Fcγ receptors are the key mediators of inflammation in Gram-positive sepsis." dans: Journal of immunology (Baltimore, Md. : 1950), Vol. 189, Issue 5, pp. 2423-31, (2012) (PubMed).
: "Interaction with Fc?RIIB is critical for the agonistic activity of anti-CD40 monoclonal antibody." dans: Journal of immunology (Baltimore, Md. : 1950), Vol. 187, Issue 4, pp. 1754-63, (2011) (PubMed).
: "Discovery and characterization of a peptide motif that specifically recognizes a non-native conformation of human IgG induced by acidic pH conditions." dans: The Journal of biological chemistry, Vol. 284, Issue 15, pp. 9986-93, (2009) (PubMed).
: "Restoration of tolerance in lupus by targeted inhibitory receptor expression." dans: Science (New York, N.Y.), Vol. 307, Issue 5709, pp. 590-3, (2005) (PubMed).
Synonymes et noms alternatifs relatifs à FCGR2B
Fc fragment of IgG receptor IIb (FCGR2B), Fc fragment of IgG, low affinity IIb, receptor (CD32) (FCGR2B), Fc receptor, IgG, low affinity IIb (Fcgr2b), Fc fragment of IgG receptor IIb (Fcgr2b), low affinity immunoglobulin gamma Fc region receptor II (LOC100856270), AI528646, CD32, CD32B, F630109E10Rik, FCG2, FCGR2, Fcgr2, Fcgr2a, FCGR2B, FcgRII, Fcr-2, Fcr-3, FCRII, FcRII, Fc[g]RII, IGFR2, Ly-17, Ly-m20, LyM-1, Lym-1Protein level used designations for FCGR2B
- CDw32
- Fc fragment of IgG, low affinity II, receptor for (CD32)
- Fc fragment of IgG, low affinity IIb, receptor for (CD32)
- Fc gamma RIIb
- fc-gamma RII-b
- fc-gamma-RIIb
- fcRII-b
- igG Fc receptor II-b
- low affinity immunoglobulin gamma Fc region receptor II-b
- Fc fragment of IgG, low affinity IIb, receptor (CD32)
- Fc fragment of IgG, low affinity IIb, receptor
- IgG Fc gamma receptor II
- fc-gamma RII
- fcRII
- igG Fc receptor II
- low affinity immunoglobulin gamma Fc region receptor II
- Fc gamma RIIB
- Fc-gamma-RII
- FcgammaRIIB
- fc gamma receptor IIB
- fc-gamma-RIIB
- igG Fc receptor II beta
- lymphocyte antigen 17
- FC-gamma RII
- Fc receptor, IgG, low affinity IIb
- low affinity immunoglobulin gamma FC region receptor II
- Fc-gamma RII
- IgG Fc receptor II
- Fc gamma receptor II
Vous êtes ici:
